Munich, Germany, June 2025 – biosyn Arzneimittel GmbH, a pharmaceutical and biotechnology company specializing in trace elements, announces a strategic partnership in the field of digital therapy support together with XO Life, a leading digital health scale-up. As part of this collaboration, biosyn’s therapy areas will be made available via the brite™ platform through web access or via the iOS and Android app. After free registration, users will have 24/7 access to reliable, easy-to-understand, and validated medical information. Additionally, they can document their therapy progress, gain personalized insights, and receive expert support when needed. The brite™ platform also enables exchange with other users—for mutual motivation and emotional support. With its versatile features, the platform can help users adhere more reliably to their therapy regimens.
Informative, personalized, and available 24/7:
Free digital therapy support
The new biosyn areas on the brite™ platform provide information about biosyn products, offer reminder functions, and feature intuitive navigation. Practical usage tips, videos, and the ability to document intake and application can support users in carrying out their therapy. Patients can also share their experiences and interact with others. The systematic recording of individual patient experiences, known as Patient-Reported Experiences (PREs) or Patient-Reported Outcomes (PROs), can be shared with the treating physician. This digital support is not a substitute for medical advice but can complement medical care with clear and easily accessible information.
Digital support for transparency and trust
The brite™ platform creates added value by presenting medical content in an understandable way and supporting users in their daily lives. With their joint approach, biosyn and XO Life aim to promote transparency and strengthen consistent application throughout the therapy process.
“Consistent and safe application is not always a given. That’s why at biosyn, we believe in combining high-quality preparations with smart digital support. With the brite™ platform, we aim to create precisely this connection,”
says Michaela Ast, BU Head of Marketing & Sales at biosyn.
Dr. Friderike Bruchmann, Co-Founder & CEO of XO Life, adds:
“Well-informed users can make autonomous decisions about their health. Our collaboration with biosyn supports clear, everyday-relevant, and reliable communication.”
About biosyn Arzneimittel GmbH
biosyn Arzneimittel GmbH is a pharmaceutical and biotech company based in Fellbach. It specializes in trace elements, is the global market leader for high-dose selenium injections, and operates two unique GMP-certified active ingredient production sites worldwide. biosyn is also active in the biotech sector with a glycoprotein derived from Megathura crenulata, a marine snail native to California. 70% of its revenue is generated outside Germany—across 27 countries worldwide.
Active in oncology, intensive care, and endocrinology, biosyn is a partner for hospitals and outpatient physicians in integrative medicine, which combines conventional medicine with naturopathy.
More information:
Website: https://biosyn.de
Instagram: @biosyn_we.care
Facebook: biosyn Arzneimittel
LinkedIn: biosyn Arzneimittel GmbH
About XO Life
XO Life has created a globally unique meta-platform—brite™—for digital product and therapy support. Patients are supported during product use or therapy with verified medical and health-related content, track their health and therapy progress, receive personalized insights and expert medical support, and can connect with other patients.
Manufacturers can license their own product and therapy areas on the brite™ platform, customizing them with branding, content, questions, and services tailored to their patients. By offering personalized information and continuous support throughout treatment, manufacturers contribute significantly to therapy success, adherence, and patient safety.
XO Life is considered a key innovator in healthcare and ranks among the leading digital health scale-ups in Germany and Europe. It is the market leader in Germany and collaborates with global leaders, mid-sized German pharmaceutical companies, and orphan drug manufacturers. The brite™ platform is now available in all European countries and languages.
Website: www.xo-life.com
LinkedIn: XO Life
YouTube: XO Life Channel
Press Contact
biosyn Arzneimittel GmbH
Safinaz Ölmez-Nosworthy
Press Contact
Schorndorferstraße 32
70734 Fellbach
Email: Safinaz_Oelmez-Nosworthy@biosyn.de
XO Life GmbH
Agnes-Pockels-Bogen 1
80992 Munich
Dr. med. Lisa Marie Köhler
Head of Medical Affairs & Pharmacovigilance
Email: pr@xo-life.com
Sources:
-
Statista Infographic: Statista – Consumption of Supplements in Germany (June 2025)
-
Federal Office of Consumer Protection and Food Safety: Supplements vs. Pharmaceuticals
